Keyphrases
Alzheimer's Disease
66%
Agitation
27%
Neuropsychiatric Symptoms
27%
Dementia
21%
Apathy
19%
Mild Cognitive Impairment
14%
Methylphenidate
13%
Neuropsychiatric Inventory Questionnaire (NPI-Q)
11%
Citalopram
11%
Randomized Clinical Trial
9%
Older Adults
9%
Clinical Trials
8%
Cognitive Decline
8%
Alzheimer's Dementia
8%
Placebo
7%
Depressive Symptoms
7%
Mini-Mental State Examination
7%
Deep Brain Stimulation
6%
Cognitive Impairment
6%
Aggression
6%
Cognitive Dementia
5%
Alzheimer's Disease Patient
5%
Traumatic Brain Injury
5%
Major Depressive Disorder
5%
Alzheimer
5%
Cerebrovascular Reactivity
5%
Confidence Interval
5%
Clinical Dementia Rating
5%
Neuroscience
Alzheimer's Disease
100%
Mild Cognitive Impairment
22%
Cognitive Disorders
18%
Placebo
15%
Citalopram
13%
Electrical Brain Stimulation
13%
Methylphenidate
13%
Amyloid
9%
Sertraline
6%
Treatment of Depression
6%
Major Depressive Disorder
5%
Traumatic Brain Injury
5%
Neurotrauma
5%
Cognitive Tests
5%
Randomized Controlled Trial
5%
Depression
5%
Medicine and Dentistry
Alzheimer's Disease
39%
Symptom
17%
Cognitive Defect
10%
Patient with Alzheimer's Disease
8%
Clinical Trial
8%
Amyloid
8%
Placebo
7%
Methylphenidate
7%
Neuropsychiatric Inventory
6%
Sertraline
5%
Postoperative Delirium
5%
Biological Marker
5%
Mild Cognitive Impairment
5%
Tau
5%
Drug Therapy
5%
Hip Fracture
5%
Randomized Controlled Trial
5%